Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

October 19, 2021

Study Completion Date

January 19, 2022

Conditions
PsoriasisAtopic DermatitisAcne
Interventions
OTHER

Tailored Patient-Provider Communication

Every 1.5 months, patients randomized to the tailored patient-provider communication model will receive weblinks directing patients to disease-specific educational videos and associated questionnaires. Communication will be tailored as the mode of weblink delivery will be customized to patient preference. Patients can choose messages to be delivered via e-mail, SMS, WhatsApp, or Facebook. For example, if one patient determines SMS messaging as their preferred communication mode, then this patient will receive a weblink via SMS directing the patient to customized educational videos and questionnaires. Weblinks delivered via tailored patient-provider communication will be enabled by Wecudos.

OTHER

Non-Tailored Patient-Provider Communication

Every 1.5 months, patients randomized to the non-tailored patient-provider communication model will receive weblinks directing patients to disease-specific educational videos and associated questionnaires. Communication will be non-tailored such that patients will not be able to choose their preferred mode of communication and will receive hardcopy. Patients will receive hardcopy on how to access psoriasis education. Weblinks delivered via non-tailored patient-provider communication will be enabled by Wecudos.

Trial Locations (1)

90033

USC, Los Angeles

All Listed Sponsors
collaborator

National Psoriasis Foundation

OTHER

lead

University of Southern California

OTHER

NCT04633616 - Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients | Biotech Hunter | Biotech Hunter